Bionano Genomics (BNGO) Capital Expenditures (2017 - 2026)
Bionano Genomics (BNGO) posted Capital Expenditures of -$16000.0 for Q1 2026, down 104.85% sequentially from $330000.0 in Q2 2025, and up 95.15% YoY from -$8198.8 in Q1 2025.
Bionano Genomics (BNGO) Capital Expenditures (2017 - 2026) Analysis & Trends
Bionano Genomics has reported Capital Expenditures for 9 years, with the latest figure at -$16000.0 in Q1 2026.
- Quarterly Capital Expenditures rose 95.15% year-over-year to -$16000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $314000.0 (up 106.24% YoY) and the FY2024 annual result came in at -$4.7 million, down 376.64% from the prior year.
- Capital Expenditures retreated to -$16000.0 in Q1 2026 per BNGO's latest filing, from $330000.0 in the prior quarter.
- Over five years, Capital Expenditures peaked at $1.6 million in Q4 2022 and troughed at -$4.8 million in Q4 2024.
- A 5-year average of -$42500.0 and a median of $203500.0 in 2023 frame the typical range for Capital Expenditures.
- The sharpest annual moves came in 2022 and 2025: Capital Expenditures jumped 1227.63% in 2022, then tumbled 1369.23% in 2025.
- Over 5 years, Capital Expenditures stood at $1.6 million in 2022, then dropped by 18.96% to $1.3 million in 2023, then sank by 480.35% to -$4.8 million in 2024, then surged by 106.9% to $330000.0 in 2025, then plunged by 104.85% to -$16000.0 in 2026.
- According to Business Quant data, Capital Expenditures over the past three periods registered -$16000.0, $330000.0, and -$330000.0 for Q1 2026, Q2 2025, and Q1 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 112.60 Mn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 143.00 Mn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | 374.00 Mn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 51.13 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 111.00 Mn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 43.20 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 83.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 86.40 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 116.00 Mn |
| 10 | Bionano Genomics | 13.74 Mn | 3.81 Mn | 4.31 Mn | -575,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -575,000.00 |
| Jun 30, 2026 | -575,000.00 |
| Mar 31, 2026 | -16,000.00 |
| Mar 31, 2026 | -16,000.00 |
| Jun 30, 2025 | 330,000.00 |
| Jun 30, 2025 | 330,000.00 |
| Mar 31, 2025 | -330,000.00 |
| Mar 31, 2025 | -330,000.00 |
| Dec 31, 2024 | -4.78 Mn |
| Dec 31, 2024 | -4.78 Mn |
| Jun 30, 2024 | 77,000.00 |
| Jun 30, 2024 | 77,000.00 |
| Mar 31, 2024 | 26,000.00 |
| Mar 31, 2024 | 26,000.00 |
| Dec 31, 2023 | 1.26 Mn |
| Dec 31, 2023 | 1.26 Mn |
| Sep 30, 2023 | 330,000.00 |
| Sep 30, 2023 | 330,000.00 |
| Jun 30, 2023 | -256,000.00 |
| Jun 30, 2023 | -256,000.00 |